Abstract:To investigate the antitumor effect of iridium complexes, three iridium (III) complexes [Ir(ppy)(2)(dcdppz)]PF6(ppy = 2-phenylpyridine, dcdppz = 11,12-dichlorodipyrido [3,2-a:2',3'-c]phenazine) (Ir1), [Ir(bzq)(2)(dcdppz)] PF6 (bzq = benzo[h]quinoline) (Ir2) and [Ir(piq)(2)(dcdppz)]PF6 (piq = 1-phenylisoquinoline) (Ir3) were synthesized and characterized. Geometry optimization, molecular dynamics simulation and docking studies have been performed to further explore the antitumor mechanism. The cytotoxicity of Ir1-3 toward cancer cells was studied by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MIT) method. The localization of complexes Ir1-3 in the mitochondria, intracellular accumulation of reactive oxygen species (ROS) levels, the changes of mitochondrial membrane potential and morphological changes in apoptosis were investigated. Flow cytometry was applied to quantify fluorescence intensity and determine cell cycle distribution. Western blotting was used to detect the expression of apoptosis-related proteins. The anti-tumor effect of Ir1 in vivo was evaluated. The results showed that Ir1-3 had high cytotoxicity to most tumor cells, especially to SGC-7901 cells with a low IC50 value. Ir1-3 can increase the intracellular ROS levels, reduce the mitochondrial membrane potential. Additionally, the complexes induce an increase of apoptosis-related protein expression, enhance the percentage of apoptosis. The complexes inhibit the cell proliferation at G0/G1 phase. The results obtained from antitumor in vivo indicate that Irl can significantly inhibit the growth of tumors with an inhibitory rate of 54.08%. The docking studies show that complexes Ir1-3 interact with DNA through minor-groove intercalation, which increases the distance of DNA base pairs, leading to a change of DNA helix structure. These experimental and theoretical findings indicate that complexes Ir1-3 can induce apoptosis in SGC-7901 cells through the mitochondrial dysfunction and DNA damage pathways, and then exerting anti-tumor activity in vitro and vivo.

Anticancer effect evaluation of iridium(III) complexes targeting mitochondria and endoplasmic reticulum.

Evaluation of anticancer effects in vitro of new iridium(III) complexes targeting the mitochondria

Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria

Induction of apoptosis in SGC-7901 cells by iridium(III) complexes via endoplasmic reticulum stress-mitochondrial dysfunction pathway

Exploring anticancer efficiency of mitochondria-targeted cyclometalated iridium(III) complexes

Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells

Enhanced in Vitro Cytotoxicity and Antitumor Activity in Vivo of Iridium(iii) Complexes Liposomes Targeting Endoplasmic Reticulum and Mitochondria

Synthesis, Biological Evaluation of Novel Iridium(iii) Complexes Targeting Mitochondria Toward Melanoma B16 Cells.

Synthesis, evaluation of biological activity studies of iridium(III) complexes against human gastric carcinoma SGC-7901 cells

Mitochondria-targeted Neutral and Cationic Iridium(iii) Anticancer Complexes Chelating Simple Hybrid Sp2-N/sp3-n Donor Ligands.

Mitochondria-targeted Phosphorescent Cyclometalated Iridium(iii) Complexes: Synthesis, Characterization, and Anticancer Properties

DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes

Half-sandwich Iridium N-heterocyclic Carbene Anticancer Complexes

Synthesis and Evaluation of Iridium(iii) Complexes on Antineoplastic Activity Against Human Gastric Carcinoma SGC-7901 Cells

Antitumor activity studies of iridium (III) polypyridine complexes-loaded liposomes against gastric tumor cell in vitro

Mitochondria-targeted Cyclometalated Iridium (III) Complexes: Dual Induction of A549 Cells Apoptosis and Autophagy.

Lysosome-Targeted Phosphine-Imine Half-Sandwich Iridium(III) Anticancer Complexes: Synthesis, Characterization, and Biological Activity

Cytotoxic and Apoptosis-Inducing Activities of Iridium Complexes Bearing 2-Phenylimidazo[4,5-f][1,10]-Phenanthroline Derivatives in Human Cancer Cells

Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents

Design and Anticancer Behaviour of Cationic/neutral Half-Sandwich Iridium (III) Imidazole-Phenanthroline/phenanthrene Complexes

Design, synthesis, and evaluation of phosphorescent Ir(III) complexes with anticancer activity.